Glycovax Pharma
Chemicals & Related Products · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
424 Guy St Ste 202, Montreal, Quebec, H3...Phone Number
(438) 393-5009Website
www.glycovax.comRevenue
<$5 MillionIndustry
About Glycovax Pharma
Glycovax Pharma Org Chart
Is Glycovax Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Glycovax Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Glycovax Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Glycovax Pharma
Check out if Glycovax Pharma is spiking on competitors!
Earning: See what the market has to say on Glycovax Pharma recently announced quarterly report
Product Launch: Get notified when Glycovax Pharma launches new products
Website visits: Recent activity has been detected on your website
Click to see if Glycovax Pharma had a recent Job posting/layoffs
Check if Glycovax Pharma has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Glycovax Pharma as Masked Content
Find 2 more new buyers
Compare Similar Companies to Glycovax Pharma
Compare insights from companies similar to Glycovax Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Glycovax Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Glycovax Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Glycovax Pharma.
Glycovax Pharma Tech Stack
A closer look at the technologies used by Glycovax Pharma
Glycovax Pharma News & Media
Glycovax Pharma, the National Research Council of Canada and the Université de Montréal, join forces to develop an innovative vaccine against the bacterium Pseudomonas aeruginosa (Pa), made possible through CQDM's financial support
Fighting respiratory diseases, particularly in hospitals MONTRÉAL, Oct. 8, 2025 /PRNewswire/ - Glycovax Pharma today announced a strategic collaboration with the National Research Council of Canada (NRC) and the Faculty of Veterinary Medicine at the Université de Montréal to develop a...Glycovax Pharma is granted a licence by the National Research Council of Canada to develop a vaccine to fight nosocomial disease related to Pseudomonas aeruginosa (Pa) infections
MONTREAL, Aug. 18, 2025 /PRNewswire/ - Pseudomonas aeruginosa (Pa) is a bacterium responsible for nosocomial infections and is often fatal when contracted by people living with cystic fibrosis. There is currently no vaccine to prevent Pa-related infections even though this bacterium is a...
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Glycovax Pharma
Glycovax is a pioneering company focused on developing next-generation conjugate vaccines through innovative glycoengineering to combat infectious diseases and enhance global health. The company utilizes cutting-edge glyco-technology to improve vaccine efficacy, stability, and safety. Glycovax aims to empower vaccine developers and protect communit... Read More